Organization: Health Canada
Year: 2022
Month: February
Request Number: A-2021-001602
Request Summary: For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Description of Manufacturing Process and Process Controls” (3.2.P.3.3).
Disposition: All exempted
Number of pages: 0